Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Interstitial Lung Disease with Positive ANCA Test

Sara Tedeschi, MD  |  Issue: October 2015  |  October 13, 2015

BKD1/shutterstock.com

Image Credit: BKD1/shutterstock.com

“Worst of all is the pain in my calves,” she said. “It feels like burning deep inside.” So began my first encounter with a 69-year-old woman who was referred to rheumatology clinic for evaluation of two months of constitutional symptoms and a positive ANCA test, which had been ordered by her primary care doctor. Her symptoms began in December, with fever, chills, non-productive cough and hoarseness.

She was treated with guaifenesin for a presumed viral upper respiratory infection, but two weeks passed, and the patient felt no better. Her fevers persisted, and she developed myalgias, fatigue and pain in the hands, knees and ankles without joint swelling or redness. She had no sinus symptoms, sore throat, cough, ear pain, headache, dysuria, recent travel or sick contacts. She saw her primary care doctor, who noted trace bilateral calf edema and tenderness in the MCPs, PIPs and ankles without joint fullness.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

For workup of persistent fevers, fatigue and myalgia, her primary care physician checked labs, which revealed mild leukocytosis (WBC 13.1) with a normal differential, mild anemia (HCT 34.2), thrombocytosis (Plt 458), normal creatinine (0.85) and a normal liver panel (ALT 19, AST 25, AlkP 150, T.bili 0.4, albumin 3.8) with the exception of elevated globulin (4.9). Acute-phase reactants were markedly elevated, with ESR 94 and CRP 107. Hepatitis C antibody and Lyme ELISA were negative, and TSH was low (0.3). These results prompted further bloodwork, which revealed normal ferritin (136), normal free T4 (1.1), moderately elevated rheumatoid factor (36), negative anti-CCP, positive pANCA (MPO and PR3 not checked) and positive IgG, but IgM was negative for parvo­virus, EBV and CMV. The patient was referred to rheumatology for evaluation of possible ANCA vasculitis.

Rheumatology Presentation

Prior to her appointment, I considered how to approach the positive pANCA in the setting of constitutional symptoms, elevated ESR and CRP, mild anemia and normal creatinine. Her records did not mention pulmonary symptoms, aside from cough. She did not appear to complain of neurologic symptoms or urinary changes and had denied sinus symptoms. There was no mention of illicit drug use, unusual medications or rash. The constitutional symptoms and elevated inflammatory markers seemed a loose indication for checking ANCA, so I took the positive result with a grain of salt. This was a patient for whom a thorough history and exam would be essential.

Image 1: The chest X-ray was remarkable for apical scarring, basilar atelectasis and/or scarring, bronchiectasis in the lingula and absence of lymphadenopathy.

Image 1: The chest X-ray was remarkable for apical scarring, basilar atelectasis and/or scarring, bronchiectasis in the lingula and absence of lymphadenopathy.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Conditions Tagged with:ANCA patient careClinicalDiagnosisILDInterstitial Lung Diseaseoutcome

Related Articles

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

    Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

    February 16, 2021

    Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus.  Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, sero­sitis, myalgias and/or hepatomegaly. Features…

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    ACR Winter Rheumatology Symposium: Tips for ANCA Testing

    May 1, 2013

    How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences